See also this year's filing and all EDGAR filings for this company.
PDF Report 0001722964_2023_Y_mAbs_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001722964, Y-mAbs Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 130,447,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,986,000 |
| 2 | PropertyPlantAndEquipmentNet | 604,000 |
| 3 | remainder_Assets | 7,419,000 |
| 4 | LiabilitiesCurrent | 28,284,000 |
| 5 | LiabilitiesNoncurrent | 1,701,000 |
| 6 | remainder_Liabilities | 2,250,000 |
| 7 | CostOfGoodsAndServicesSold | 7,467,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 60,939,000 |
| 9 | ResearchAndDevelopmentExpense | 91,572,000 |
| 10 | remainder_Expenses | 100,000 |
| 11 | remainder_Revenues | 65,267,000 |
| 12 | remainder_NetIncome | -757,000 |
| 13 | remainder_ComprehensiveNetIncome | -40,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 141,456,000 |
| 1 | Liabilities | 32,235,000 |
| 2 | Expenses | 160,078,000 |
| 3 | Revenues | 65,267,000 |
| 4 | StockholdersEquity | 109,221,000 |
| 5 | NetIncome | -95,568,000 |
| 6 | ComprehensiveNetIncome | -95,588,000 |
| 7 | BaseVar | 199,916,500 |
| 8 | EconomicCapitalRatio | 1.06 |
Edgar->Model Mapping
Feature Distribution
Change over Time
